Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Extended Model‐Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
Extended Model‐Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Mohamed A. Kamal
,
Samit Ganguly
,
Ananth Kadambi
,
Patrick F. Smith
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Clinical Pharmacology & Therapeutics
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3357
Similar Items
Clinical Benefit, Trials, and Regulatory Approval of Oncology Indications Under Multiple Expedited Programs for Drug Marketing in China, 2018–2024
by: Jie Zhang, et al.
Published: (2025)
Impact of Model‐Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost
by: Vaishali Sahasrabudhe, et al.
Published: (2025)
Model‐Informed Drug Development Supports Full Approval of Ibuprofen Injection in Chinese Pediatric Patients With Fever or Pain
by: Qianxi Lou, et al.
Published: (2025)
Characteristics of Drugs from Non‐Global Companies for Hematologic Malignancies and Impact on Global Regulatory Approval
by: Kensuke Matsuda, et al.
Published: (2024)
Model‐Informed Drug Development‐Based Bridging from Subcutaneous to Intravenous Secukinumab Dosing: Approval in Psoriatic Arthritis and Axial Spondyloarthritis
by: Thomas Dumortier, et al.
Published: (2025)